MULLENNIX STEPHEN (COO) sold 8.5% of their position (608.00 shares) of UROGEN PHARMA LTD. on the open market
Open‑market sale worth $19.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/16/2019ACC: 0001209191-19-046282
-608.00
Net shares
Net seller
$19.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.76K acquired · 2.37K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+1.76K
Price / share
—
Trade value
—
% of position
32.7%
8/14/2019
5.38K→7.14K
Ordinary Shares
Direct
Shares
−608.00
Price / share
$31.65
Trade value
$19.24K
% of position
8.5%
8/15/2019
7.14K→6.53K
Total
Net shares
+1.15K
Net value
-$19.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/14/2019 | M · Option Exercise | +1.76K | — | — | 32.7% | 5.38K | 7.14K |
| Ordinary Shares Direct | 8/15/2019 | S · Sale | −608.00 | $31.65 | $19.24K | 8.5% | 7.14K | 6.53K |
| Total | +1.15K | -$19.24K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Ordinary Shares
1.76K shares
Shares
−1.76K
Strike price
Held after
10.55K
Exercisable
—
8/14/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Ordinary Shares1.76K shares | 8/14/2019 | M · Option Exercise | −1.76K | — | 10.55K |